Answers are grounded in this paper and cite their sources.
Hydroxychloroquine (HCQ) suppresses an interleukin-1β-granulocyte-macrophage colony-stimulating factor cytokine axis, reported to be dysregulated in peripheral blood mononuclear cells of acute rheumatic fever patients ex vivo. We describe HCQ treatment for 2 patients with rheumatic carditis and a protracted inflammatory course. HCQ was associated with control of inflammatory markers, control of pericarditis in first patient and stabilization of progressive carditis in the second patient.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: